Disclaimer: You are now leaving www.HIVReagentProgram.org and are going to a website that is not operated by NIH HIV Reagent Program. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE: NIH HIV Reagent Program offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the NIH HIV Reagent Program website and will be redirected to another site. These sites are not under the control of NIH HIV Reagent Program. NIH HIV Reagent Program is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Please read third party privacy and security policies closely as these may be different than NIH HIV Reagent Program policies. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
All reagents are provided world-wide at no cost. While there is no cost for the reagents themselves, additional shipping charges apply and you must provide us with your account number to a shipping carrier (e.g. FedEx, World Courier, etc.) in the shopping cart.
To register you must be affiliated with a public, private, academic, non-profit or for-profit institution. Registrants must demonstrate they work in an established institution with facilities and safety programs appropriate for the level of registration requested. The HIV Reagent Program encourages individuals and organizations to take advantage of our institutional registration process when more than one qualified researcher at an organization is interested in receiving materials from the HIV Reagent Program.
Reagent depositors are asked to state the restrictions on commercial use of their reagents. Scientists who wish to use reagents for commercial purposes can only do so under the terms of the release category specified by the donor. The five release categories are:
A - Reagent may be used for commercial purposes without an agreement with the donor. B - Recipient agrees to negotiate in good faith to share with the donor' s institution the income arising from commercializing the reagent (Form Required). C - Recipient must sign an agreement with the donor' s institution for commercial use prior to receiving the reagent. D - Recipient must Release Category B or C prior to receiving the reagent (Form Required). E - Recipient must not use or incorporate the reagent for commercial purposes. (Reagent cannot ever be distributed from our program to a commercial institution for ANY use. Reagent will be distributed for n ...
Yes. The HIV Reagent Program can accept mailed, faxed, scanned and emailed copies of the registration documents. E-Mail all documents with electronic or ink signatures to: contact@HIVReagentProgram.org Fax all documents with electronic or ink signatures to: (703) 365-2898. The original documents can be sent to us via the courier of your choice to:
HIV Reagent Program Customer Service: Registration 10801 University Boulevard Manassas, VA 20110-2209
Please allow 1-2 weeks after delivery of your registration package for processing and approval. Missing, incomplete or inaccurate information and documents can extend processing time. Once your application has been reviewed and approved by NIAID, we will notify you by email with information on how to proceed with accessing your online account for the purposes of placing your order.
Shapiro SZ. HIV Vaccine Development: 35 Years of Experimenting in the Funding of Biomedical Research. Viruses. 2020 12(12):1469. https://doi.org/10.3390/v12121469
Abed, H.H., A.M. Ali, and Z.S. Mahdi, Effect of Vitamin D3 Supplement on the Semen Quality in Human Patients with Vitamin D Deficiency. HAYATI Journal of Biosciences, 2022. 29(5): p. 562-569.
Acke, A., et al., Expansion microscopy allows high resolution single cell analysis of epigenetic readers. Nucleic Acids Research, 2022.
Acosta, R.K., et al., Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro. Antimicrobial Agents and Chemotherapy, 2022. 66(5): p. e02038-21.
Adelakun, S.A., et al., Histomorphometric and biochemical activities of bioactive component of Cyperus esculentus tubers extract on letrozole-induced polycystic ovarian syndrome and cholesterol homeostasis in female Sprague-Dawley rats. Toxicology Research and Application, 2022.& ...